DALLAS, Sept. 2, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring InoLife Technologies Inc. (OTCBB:INOL). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at:
InoLife Technologies Inc. (INOL), formerly NexxNow Inc., is a development-stage company. The Company is a service-based healthcare products development, integration and marketing company, primarily focused upon products, services and solutions. It operates two lines of businesses both in the medical field. Its first line of business is the development of veterinary oncological treatments (cancer in animals). Its second line of business is to provide deoxyribonucleic acid (DNA) testing for paternity tests and to screen for certain genetic diseases. It licenses the DNA test kits. The principal users of its products and services include healthcare providers, including physicians, veterinarians, hospitals and outpatient facilities, in addition to individuals with a direct need for the solutions it provides. INOL is organized to address two specific, but different, markets: the companion animal (dogs and cats) healthcare market and the human healthcare market.
Message Board Search for INOL:
In the report, the analyst notes:
"The Company realized a net loss of $ 37,563 for the three months ended June 30, 2010. During the period from inception to June 30, 2010, INOL realized an Accumulated Deficit of $1,130,890, primarily due to a total of $759,590 of Losses Due to Recapitalization Expenses during the period from inception to June 30, 2010.
"INOL recently announced it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient's genetic makeup may affect the body's response to Plavix (colpidogrel)."
To read the entire report visit:
See what investors are saying about INOL at
Get breaking news on INOL at
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit:
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.
CONTACT: MicroStockProfit.com Brian Johnson 1-888-307-2850 firstname.lastname@example.org